104 272

Cited 0 times in

Cited 0 times in

Seroprevalence of anti-diphtheria toxoid antibody and implications for vaccination policy in Vietnam's South-central coast: a cross-sectional study

Authors
 Le, Hoang Thieu  ;  Do, Thai Hung  ;  Dao, The Anh  ;  Hoang, Tien Thanh  ;  Nguyen, Bao Trieu  ;  Le, Thuy Lien  ;  Nguyen, Dinh Luong  ;  Yoshida, Lay-Myint  ;  Le, Xuan Huy  ;  Le, Hong Quan  ;  Ton, That Toan  ;  Ha, Min Jin 
Citation
 BMC INFECTIOUS DISEASES, Vol.24(1), 2024-08 
Article Number
 813 
Journal Title
BMC INFECTIOUS DISEASES
ISSN
 1471-2334 
Issue Date
2024-08
Keywords
Seroprevalence ; Anti-diptheria toxoid antibody ; Vietnam
Abstract
Background Diphtheria is a re-emerging infectious disease and public health concern worldwide and in Vietnam with increasing cases in recent years. This study aimed to assess the anti-diphtheria toxoid antibodies status in Khanh Hoa Province and identify factors contributing to the vaccination policy in the south-central coast of Vietnam. Methods This was a cross-sectional study to evaluate the seroprevalence of anti-diphtheria toxoid antibodies among 1,195 participants, aged 5 - 40 years in Khanh Hoa Province, Vietnam. Immunoglobulin G antibody levels against diphtheria were detected using a commercial anti-diphtheria toxoid enzyme-linked immunosorbent assay (SERION ELISA classic Diphtheria Immunoglobulin G) and were categorized following the World Health Organization guidelines. Results The mean anti-diphtheria toxoid antibody levels were 0.07 IU/ml (95% Confidence Interval: 0.07-0.08). Anti-diphtheria toxoid antibody levels were found to be associated with age and history of diphtheria vaccination. The 5-15 years age group had the highest levels (0.09 IU/ml), while the older age group had the lowest antibody level (p < 0.001). Individuals who received three doses (adjusted Odds ratio: 2.34, 95%CI: 1.35 - 4.07) or 4(+) doses (adjusted Odds ratio: 2.45, 95%CI: 1.29 - 4.64) had a higher antibody level compared to those who received only one dose regardless of age. Conclusion It is crucial to promote routine vaccination coverage to over 95% for children under one year of age with three primary doses of the diphtheria-containing vaccine, including additional doses at 18 months and 7 years of age. Booster doses should be promoted and administered to adolescents and adults every 10 years.
DOI
10.1186/s12879-024-09688-0
Appears in Collections:
5. Graduate School of Transdisciplinary Health Sciences (융합보건의료대학원) > Graduate School of Transdisciplinary Health Sciences (융합보건의료대학원) > 1. Journal Papers
Yonsei Authors
Ha, Min Jin(하민진)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/200482
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links